What are the next steps for a patient with a negative (NIL) Papanicolaou (Pap) smear but positive Human Papillomavirus (HPV) test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Negative Pap Smear with Positive HPV Test

For a patient with a negative Pap smear (NIL) and positive HPV test, the recommended next step is to repeat both HPV testing and cytology in 12 months. 1

Risk Assessment and Management Algorithm

The finding of a negative Pap smear with positive HPV represents a clinically significant scenario that requires appropriate follow-up. The management approach depends on several factors:

Initial Management

  1. Repeat co-testing at 12 months (HPV test plus Pap smear) is the preferred approach 1

    • This allows time to determine if the HPV infection will persist or clear naturally
    • Avoids unnecessary colposcopy for transient infections
  2. Alternative approach: HPV genotyping if available

    • If positive for HPV types 16 or 18, proceed directly to colposcopy 1
    • These high-risk types have stronger association with cervical cancer

Follow-up at 12 months:

  • If both HPV and cytology are negative: Return to routine screening 2
  • If HPV remains positive OR cytology shows ASC-US or worse: Refer for colposcopy 1, 2

Special Considerations

Age-specific management:

  • For women ≥30 years: The above algorithm applies
  • For women <30 years: HPV testing is generally not recommended for primary screening, but if performed and positive with negative cytology, follow the same 12-month follow-up protocol 1

Risk factors requiring closer monitoring:

  • Previous abnormal results
  • Immunosuppression
  • History of high-grade lesions

Evidence Quality and Rationale

The recommendation for 12-month follow-up rather than immediate colposcopy is based on the understanding that:

  1. Most HPV infections are transient and will clear spontaneously within 1-2 years 3
  2. The risk of high-grade cervical intraepithelial neoplasia (CIN 2+) in women with negative cytology but positive HPV is relatively low (approximately 5.7%) 4
  3. The negative predictive value of HPV testing is very high (>99%) 4

Common Pitfalls to Avoid

  • Overtreatment: Avoid immediate colposcopy or treatment without evidence of cellular abnormalities
  • Undertreatment: Don't return to routine screening without appropriate follow-up
  • Poor documentation: Ensure all test results and follow-up plans are clearly documented 1
  • Loss to follow-up: Develop systems to track patients who need repeat testing

Documentation Requirements

Document the following in the patient's record:

  • HPV test result (including genotype if available)
  • Pap test result
  • Follow-up plan with specific timeframe
  • Patient education provided regarding the significance of results

The 2019 American Society for Colposcopy and Cervical Pathology (ASCCP) risk-based management guidelines support this approach, focusing on the patient's risk of developing cervical precancer rather than specific test results alone 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cervical Cancer Screening and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.